Drug Reference
Cellulose
OTC
Fact box
- Habit forming
- No
- Availability
- Over-the-counter (OTC)
Brand names
Unifiber
Available as
3000 MG · Powder
FDA label sections are from openFDA and may not reflect the most recent labeling — confirm against the current DailyMed label.
Uses
Directions Instill 1 or 2 drops in the affected eye(s) as needed and discard container.
How to use / dosing
Questions or comments? Call 1-888-645-8204 Monday-Friday 9AM-5PM (PST) Distributed by: UNITED EXCHANGE CORP. Cypress, CA 90630 USA | 1-888-645-8204 Made in U.S.A.
Safety advice
Conservative summary derived from FDA labeling — defaults to “consult your doctor” unless the label is explicit. Not a substitute for your clinician’s advice.
PregnancyNo information
No specific information in the FDA label.
BreastfeedingNo information
No specific information in the FDA label. Check LactMed →
AlcoholNo information
No specific information in the FDA label.
DrivingNo information
No specific information in the FDA label.
KidneyNo information
No specific information in the FDA label.
LiverNo information
No specific information in the FDA label.
Warnings & precautions
Warnings For use in the eyes only.
Current FDA labels (DailyMed)
- CLE DE PEAU BEAUTE RESTORATIVE DAY SUPREME (AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]
- DD CREAM DERMATOLOGICALLY DEFINING BB CREAM BROAD SPECTRUM SPF 30 CREAM [PML NYC, LLC]
- SHISEIDO VITAL PERFECTION UPLIFTING AND FIRMING DAY (AVOBENZONE, OCTINOXATE, OCTOCRYLENE, AND HOMOSALATE) CREAM [SHISEIDO AMERICAS CORPORATION]
- SHISEIDO ULTIMATE SUN PROTECTOR (OCTISALATE, TITANIUM DIOXIDE, OCTOCRYLENE, AND ZINC OXIDE) CREAM [SHISEIDO AMERICAS CORPORATION]
- K FLUSH (BELLADONNA, BERBERLS VULGARLS, CANTHARIS, , HYDRANGEA, PARELRA BRAVA, RUBLA TINCT, SOLIDAGO, SARSAPARILLA, URTICA URENS ) SYRUP [DR. MASOOD HOMEOPATHIC PHARMACEUTICALS PRIVATE LIMITED]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.